The story of Viagra presents a nuanced case for stakeholders in the drug sector. While initially a blockbuster success, creating billions, the intellectual property end and the subsequent flood of cheaper competitors https://pharma647365.59bloggers.com/42115535/the-little-copyright-and-big-pharma-a-risky-play